Neuronetics
Neuronetics, Inc. is a commercial stage medical technology company that specializes in developing non-invasive therapies for psychiatric disorders. Founded in 2003 and headquartered in Malvern, Pennsylvania, the company markets the NeuroStar Advanced Therapy System, which provides a non-invasive treatment for adults suffering from major depressive disorder. This system employs transcranial magnetic stimulation (TMS) to generate a pulsed, MRI-strength magnetic field that induces electrical currents aimed at stimulating specific brain areas linked to mood regulation. Neuronetics sells its products primarily through a dedicated sales and customer support team targeting psychiatrist customers, focusing on improving the quality of life for individuals with mental health challenges.
Greenbrook TMS Inc. operates a network of outpatient mental health service centers across the United States, specializing in transcranial magnetic stimulation (TMS) therapy. This FDA-cleared, non-invasive treatment offers electromagnetic stimulation to brain regions involved in mood regulation, primarily targeting major depressive disorder and other mental health conditions. Founded in 2011 and headquartered in Toronto, Canada, Greenbrook TMS manages approximately 121 treatment centers nationwide, providing accessible care for individuals seeking innovative solutions for their mental health challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.